Company profile
3P Innovation Limited
3P Innovation
3P Innovation Limited is a UK company with status active founded in 2006 based in West Midlands.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Aseptic Cell Processing
1 Sep 2022 to 28 Feb 2023
Pharmaceutical and drug manufacturing has remained largely unchanged for decades, manufacturing mass volume largely one size fits all therapies, most aimed at treating symptoms but not curing rare and life changing diseases. However, the last decade has seen huge progress in cell therapies and gene therapies at lab scale, known as Advanced Therapy Medicin...
Emergency Community Visor Production
1 Jul 2020 to 31 Mar 2021
The rapidly developing COVID-19 and ensuing PPE shortage has left the NHS resorting to lots of hobbyist grade or improvised visors to provide basic protection while treating patients. We are shipping an open sourced 3D printed design at the moment but are bottle-necked by prototype processes. The visors are one of the best methods of infection prevention ...
INFINIte varieTY in confectionary manufacturing using new automation technology (INFINITY)
1 Nov 2013 to 31 Jan 2016
It is currently impossible to precisely control the deposition of inclusions in moulded chocolate products at large commercial scales. Inclusions (typically nuts, raisins etc.) are very difficult to handle and they are currently mixed with chocolate prior to dispensing. This approach significantly limits the precision of metering and placement of the incl...
Novel Automatic Dual Chamber Reconstitution Injectable Drug Delivery Device
1 Jun 2013 to 31 Jan 2014
Most new pharmaceuticals under development are injectable large molecule biopharmaceuticals. Unstable in solution they require either reconstitution or costly and often impractical cold chain logistics. Current reconstitution devices are manufactured using an inefficient process and can suffer from poor mixing. There is a need for a reconstitution injecti...